167 related articles for article (PubMed ID: 11711867)
1. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.
Fatemi SH; Earle JA; Stary JM; Lee S; Sedgewick J
Neuroreport; 2001 Oct; 12(15):3257-62. PubMed ID: 11711867
[TBL] [Abstract][Full Text] [Related]
2. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
Thompson PM; Egbufoama S; Vawter MP
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
[TBL] [Abstract][Full Text] [Related]
3. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
[TBL] [Abstract][Full Text] [Related]
4. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.
Fatemi SH; Earle JA; McMenomy T
Mol Psychiatry; 2000 Nov; 5(6):654-63, 571. PubMed ID: 11126396
[TBL] [Abstract][Full Text] [Related]
5. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics.
Mukaetova-Ladinska E; Hurt J; Honer WG; Harrington CR; Wischik CM
Neurosci Lett; 2002 Jan; 317(3):161-5. PubMed ID: 11755264
[TBL] [Abstract][Full Text] [Related]
6. Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression.
Damadzic R; Shuangshoti S; Giblen G; Herman MM
Acta Neuropathol; 2002 May; 103(5):488-94. PubMed ID: 11935265
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
Guilarte TR; Hammoud DA; McGlothan JL; Caffo BS; Foss CA; Kozikowski AP; Pomper MG
Schizophr Res; 2008 Feb; 99(1-3):324-32. PubMed ID: 18191545
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.
Thompson PM; Sower AC; Perrone-Bizzozero NI
Biol Psychiatry; 1998 Feb; 43(4):239-43. PubMed ID: 9513732
[TBL] [Abstract][Full Text] [Related]
9. Homer1a protein expression in schizophrenia, bipolar disorder, and major depression.
Leber SL; Llenos IC; Miller CL; Dulay JR; Haybaeck J; Weis S
J Neural Transm (Vienna); 2017 Oct; 124(10):1261-1273. PubMed ID: 28815330
[TBL] [Abstract][Full Text] [Related]
10. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression.
Weis S; Llenos IC; Sabunciyan S; Dulay JR; Isler L; Yolken R; Perron H
J Neural Transm (Vienna); 2007; 114(5):645-55. PubMed ID: 17219017
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
13. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
Law AJ; Deakin JF
Neuroreport; 2001 Sep; 12(13):2971-4. PubMed ID: 11588613
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.
Eastwood SL; Harrison PJ
Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554
[TBL] [Abstract][Full Text] [Related]
16. Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
Shapiro J; Belmaker RH; Biegon A; Seker A; Agam G
J Neural Transm (Vienna); 2000; 107(5):603-7. PubMed ID: 11072754
[TBL] [Abstract][Full Text] [Related]
17. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
McCullumsmith RE; Kristiansen LV; Beneyto M; Scarr E; Dean B; Meador-Woodruff JH
Brain Res; 2007 Jan; 1127(1):108-18. PubMed ID: 17113057
[TBL] [Abstract][Full Text] [Related]
18. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.
Chambers JS; Perrone-Bizzozero NI
Neurochem Res; 2004 Dec; 29(12):2293-302. PubMed ID: 15672553
[TBL] [Abstract][Full Text] [Related]
19. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
20. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.
Eastwood SL; Harrison PJ
Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
